The study of curalin as add-on therapy in adults with type 2 diabetes mellitus

illustrative image

CuraLife is starting a new clinical trial of Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus.

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Curalin As Add-On Therapy in Adults with Type 2 Diabetes Mellitus.

The clinical trial started in October 15, 2021 and will continue throughout June 30, 2023. The locations are the Soroka Medical Center, Be'er Sheva, Israel; Lin Medical Center, Haifa, Israel; Herzelia Diebetes Center, Herzliya, Israel; Ichilov Medical Center, Tel Aviv, Israel.

For the inclusion and exclusion criteria please follow the link: https://ichgcp.net/clinical-trials-registry/NCT05631431.

Clinical Research News

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma

Prochains essais cliniques

The study of curalin as add-on therapy in adults with type 2 diabetes mellitus

All jobs

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner